Silverarc Capital Management

Latest statistics and disclosures from Silverarc Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Silverarc Capital Management

Companies in the Silverarc Capital Management portfolio as of the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Chinook Therapeutics (KDNY) 5.7 $13M NEW 14k 902.81
Spdr Ser Tr S&p Biotech Call Option (XBI) 5.7 $13M NEW 94k 135.40
Dicerna Pharmaceuticals (DRNA) 3.8 $8.6M +14% 230k 37.32
Merus N V (MRUS) 3.0 $6.8M +31% 321k 21.07
Mirati Therapeutics (MRTX) 2.7 $6.1M +655% 38k 161.52
Veracyte (VCYT) 2.7 $6.0M +151% 151k 39.98
Morphic Hldg (MORF) 2.7 $6.0M +73% 104k 57.39
Amryt Pharma Sponsored Ads (AMYT) 2.5 $5.5M +6% 457k 12.13
Biohaven Pharmaceutical Holding (BHVN) 2.5 $5.5M +13% 57k 97.08
ImmunoGen (IMGN) 2.4 $5.5M +13% 828k 6.59
Insmed Com Par $.01 (INSM) 2.3 $5.0M -7% 177k 28.46
Research Alliance Corp Ii Com Cl A (RACB) 2.2 $5.0M 496k 10.14
Macrogenics (MGNX) 2.1 $4.8M NEW 177k 26.86
Horizon Therapeutics Pub L SHS (HZNP) 2.1 $4.7M +3% 50k 93.63

Setup an alert

Silverarc Capital Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Intra Cellular Therapies (ITCI) 2.1 $4.6M -12% 113k 40.82
Seres Therapeutics Call Option (MCRB) 2.0 $4.5M +86% 187k 23.85
Verastem (VSTM) 1.9 $4.3M -12% 1.0M 4.07
Renalytix Ads (RNLX) 1.7 $3.9M -6% 126k 30.86
Eloxx Pharmaceuticals (ELOX) 1.7 $3.8M NEW 1.9M 1.99
Medicus Sciences Acquisition Cl A Shs 1.6 $3.6M NEW 373k 9.65
Immatics SHS (IMTX) 1.5 $3.4M +592% 289k 11.61
Aclaris Therapeutics (ACRS) 1.5 $3.3M -43% 189k 17.56
Tcr2 Therapeutics Inc cs (TCRR) 1.4 $3.1M +21% 188k 16.41
Halozyme Therapeutics (HALO) 1.4 $3.0M -36% 67k 45.42
Stereotaxis Com New (STXS) 1.3 $3.0M NEW 306k 9.64
Celldex Therapeutics Com New (CLDX) 1.3 $2.9M NEW 9.9k 294.93
Adamas Pharmaceuticals (ADMS) 1.3 $2.8M +3% 539k 5.28
United Therapeutics Corporation (UTHR) 1.2 $2.7M +185% 15k 179.41
Sierra Oncology Com New (SRRA) 1.2 $2.7M +3% 139k 19.47
Social Cap Suvretta Hlds Crp Class A Ord Shs 1.1 $2.5M NEW 250k 10.12
Social Cap Suvretta Hlds Crp Class A Ord Shs 1.1 $2.5M NEW 250k 10.11
Social Cap Suvretta Hld Crpi Class A Ord Shs 1.1 $2.5M NEW 250k 10.11
Social Cap Suvretta Hlds Cp Class A Ord Shs 1.1 $2.5M NEW 250k 10.10
Helix Acquisition Corp Com Cl A (HLXA) 1.1 $2.4M +2% 234k 10.35
Nextcure (NXTC) 1.0 $2.3M NEW 286k 8.03
Aldeyra Therapeutics (ALDX) 1.0 $2.2M -40% 192k 11.33
Eyepoint Pharmaceuticals Com New (EYPT) 1.0 $2.2M -19% 242k 8.99
Otonomy (OTIC) 0.9 $2.1M +279% 953k 2.23
Curis Com New (CRIS) 0.9 $2.1M -58% 260k 8.07
Benitec Biopharma (BNTC) 0.9 $2.0M NEW 467k 4.25
Cullinan Oncology (CGEM) 0.9 $2.0M NEW 76k 25.75
Vistagen Therapeutics Com New (VTGN) 0.9 $1.9M NEW 616k 3.15
Iteos Therapeutics (ITOS) 0.9 $1.9M NEW 76k 25.65
Zentalis Pharmaceuticals (ZNTL) 0.8 $1.8M NEW 35k 53.19
Compugen Ord (CGEN) 0.8 $1.7M +178% 209k 8.28
Kura Oncology (KURA) 0.8 $1.7M +3% 83k 20.85
Affimed Therapeutics B V (AFMD) 0.8 $1.7M -59% 202k 8.50
Jounce Therapeutics (JNCE) 0.8 $1.7M -28% 251k 6.80
Mersana Therapeutics (MRSN) 0.8 $1.7M +400% 125k 13.58
Arcus Biosciences Incorporated Put Option (RCUS) 0.7 $1.7M NEW 60k 27.47
Cerevel Therapeutics Hldng I (CERE) 0.7 $1.7M NEW 15k 110.60
Cogent Biosciences (COGT) 0.7 $1.6M +65% 198k 8.11
Cyclacel Pharmaceuticals (CYCC) 0.7 $1.5M +3% 258k 5.92
Rapt Therapeutics (RAPT) 0.7 $1.5M NEW 47k 31.78
Relmada Therapeutics (RLMD) 0.7 $1.5M NEW 47k 32.01
Arena Pharmaceuticals Com New (ARNA) 0.6 $1.4M +2% 21k 68.18
Polypid SHS (PYPD) 0.6 $1.4M +3% 155k 9.06
Deciphera Pharmaceuticals (DCPH) 0.6 $1.4M -6% 37k 36.61
Chemocentryx Put Option (CCXI) 0.6 $1.3M +78% 100k 13.39
Reata Pharmaceuticals Cl A (RETA) 0.6 $1.3M NEW 9.3k 141.56
Mereo Biopharma Group Ads (MREO) 0.6 $1.3M +131% 406k 3.17
Delcath Sys Com New (DCTH) 0.6 $1.3M +147% 99k 12.61
Evogene SHS (EVGN) 0.6 $1.2M +3% 361k 3.42
Athira Pharma (ATHA) 0.5 $1.2M NEW 118k 10.24
Trillium Therapeutics Com New (TRIL) 0.4 $923k +58% 95k 9.70
Seagen (SGEN) 0.4 $905k +14% 5.7k 157.89
Wave Life Sciences SHS (WVE) 0.4 $826k -11% 124k 6.66
Akero Therapeutics (AKRO) 0.4 $819k +3% 33k 24.80
Ardelyx (ARDX) 0.3 $752k +120% 99k 7.58
Ascendis Pharma A/s Sponsored Adr (ASND) 0.3 $737k -70% 5.6k 131.63
Surface Oncology (SURF) 0.3 $705k -5% 95k 7.46
Bellus Health Com New (BLU) 0.3 $653k NEW 210k 3.11
Odonate Therapeutics Ord (ODT) 0.3 $652k -62% 187k 3.49
Viewray (VRAY) 0.3 $623k NEW 94k 6.60
Syndax Pharmaceuticals (SNDX) 0.3 $596k +73% 35k 17.16
Guardant Health (GH) 0.3 $580k -54% 4.7k 124.12
Cerus Corporation (CERS) 0.2 $528k NEW 19k 28.25
Sage Therapeutics Call Option (SAGE) 0.2 $528k -53% 9.3k 56.77
89bio (ETNB) 0.2 $524k -43% 28k 18.69
Miragen Therapeutics (VRDN) 0.2 $519k +2% 28k 18.28
Salarius Pharmaceuticals Com New (SLRX) 0.2 $500k -76% 472k 1.06
Rocket Pharmaceuticals (RCKT) 0.2 $456k +2% 10k 44.30
Apellis Pharmaceuticals (APLS) 0.2 $443k NEW 7.0k 63.20
Catabasis Pharmaceuticals In Com New (CATB) 0.2 $398k NEW 189k 2.11
Kalvista Pharmaceuticals (KALV) 0.2 $357k -70% 15k 23.99
Medicenna Therapeutics Corp. (MDNA) 0.1 $333k +2% 111k 3.01
Uniqure Nv SHS (QURE) 0.1 $288k NEW 9.3k 30.82
Madrigal Pharmaceuticals (MDGL) 0.1 $242k NEW 2.5k 97.58
Forma Therapeutics Hldgs SHS (FMTX) 0.1 $241k NEW 9.7k 24.90
Ayala Pharmaceuticals Incorporated (AYLA) 0.1 $238k NEW 23k 10.19
Eton Pharmaceuticals (ETON) 0.1 $115k NEW 19k 6.15
Chardan Healthcr Acqstn 2 *w Exp 03/05/202 (CHAQ.WS) 0.0 $85k +6% 105k 0.81
Chardan Healthcare Acqu- Ord (PHGE) 0.0 $78k +3% 14k 5.49
Calithera Biosciences (CALA) 0.0 $66k +4% 31k 2.10
Medicus Sciences Acquisition *w Exp 02/12/202 0.0 $50k NEW 50k 1.00

Past Filings by Silverarc Capital Management

SEC 13F filings are viewable for Silverarc Capital Management going back to 2020